Herbert M. Dean
Nessuna posizione attualmente
Profilo
Dr. Herbert M.
Dean, MD, is a Director-Medical Affairs at Verax Biomedical, Inc.
Dr. Dean was previously employed as President by Fallon Community Health Plan, Inc.
He received his undergraduate degree from Columbia University and a doctorate degree from Tufts University.
Precedenti posizioni note di Herbert M. Dean
| Società | Posizione | Fine |
|---|---|---|
Fallon Community Health Plan, Inc.
 Fallon Community Health Plan, Inc. Managed Health CareHealth Services Fallon Community Health Plan provides health care services. It provides insurance and self insurance products. The firm also provides medicaid and medicare advantage plans. The company was founded in 1977 and is headquartered in Worcester, MA. | Presidente | - |
Verax Biomedical, Inc.
 Verax Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Verax Biomedical, Inc. develops rapid tests for detecting bacterial contaminants in blood cells and tissues. The firm's first target application for its technology is to test for the presence of bacterial contaminants in platelets and bacterial contaminants in platelets and red blood cells represent the greatest lethal infectious risks in transfusion medicine today and no rapid, simple methods are presently available to effectively address this threat. Verax Biomedical was founded by Joe R. Sanders and Joe L. Straight in 1999 and is headquartered in Marlborough, MA. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Herbert M. Dean
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
| Tufts University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Verax Biomedical, Inc.
Verax Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Verax Biomedical, Inc. develops rapid tests for detecting bacterial contaminants in blood cells and tissues. The firm's first target application for its technology is to test for the presence of bacterial contaminants in platelets and bacterial contaminants in platelets and red blood cells represent the greatest lethal infectious risks in transfusion medicine today and no rapid, simple methods are presently available to effectively address this threat. Verax Biomedical was founded by Joe R. Sanders and Joe L. Straight in 1999 and is headquartered in Marlborough, MA. | Commercial Services |
Fallon Community Health Plan, Inc.
Fallon Community Health Plan, Inc. Managed Health CareHealth Services Fallon Community Health Plan provides health care services. It provides insurance and self insurance products. The firm also provides medicaid and medicare advantage plans. The company was founded in 1977 and is headquartered in Worcester, MA. | Health Services |
- Borsa valori
- Insiders
- Herbert M. Dean
